Description: Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. The company's Analytical Technologies segment offers instruments, reagents, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. Its Specialty Diagnostics segment provides diagnostic test kits, culture media, instruments, and associated products that are used in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. This segment offers blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, and controls and calibration verification fluids; dehydrated and prepared culture media, and collection and transport systems; and products for cancer diagnosis and medical research. The company's Laboratory Products and Services segment offers laboratory equipment, including sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, and other laboratory equipment; laboratory consumables; research and safety market solutions; and biopharma services. Thermo Fisher Scientific Inc. serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies, as well as environmental and industrial process control settings. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Home Page: www.thermofisher.com
TMO Technical Analysis
168 Third Avenue
Waltham,
MA
02451
United States
Phone:
781 622 1000
Officers
Name | Title |
---|---|
Mr. Marc N. Casper | Chairman, Pres & CEO |
Mr. Stephen Williamson | Sr. VP & CFO |
Mr. Michel Lagarde | Exec. VP & COO |
Mr. Gianluca Pettiti | Exec. VP |
Mr. Joseph R. Holmes | VP & Chief Accounting Officer |
Mr. Ryan J. Snyder | Sr. VP & Chief Information Officer |
Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer & Member of Scientific Advisory Board |
Mr. Rafael Tejada | VP of Investor Relations |
Mr. Michael A. Boxer Esq. | Sr. VP, Gen. Counsel & Sec. |
Ms. Sandy B. Pound | VP & Chief Communications Officer |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 24.4499 |
---|---|
Trailing PE: | 31.9297 |
Price-to-Book MRQ: | 5.1084 |
Price-to-Sales TTM: | 4.9176 |
IPO Date: | 1978-01-13 |
Fiscal Year End: | December |
Full Time Employees: | 130000 |